Author: admin

  • Peter Bottomley – 2016 Parliamentary Question to the Department of Health

    Peter Bottomley – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Peter Bottomley on 2016-07-20.

    To ask the Secretary of State for Health, with reference to the patient said to have been discharged unsafely by Mr Agrawal, who the responsible consultant was; and on what grounds did East Lancashire Hospitals Trust believe that Mr Agrawal had discharged that patient when he had himself been excluded from the hospital in question.

    Mr Jeremy Hunt

    This is an employer and employee matter between the East Lancashire Hospitals NHS Trust and Mr Aditya Agrawal respectively. The Department cannot comment on individual employment matters that are the responsibility of independent organisations, and that are subject to ongoing legal proceedings or on matters relating to individual clinical cases or other personal information. We understand that the cost to East Lancashire Trust of legal proceedings concerning Mr Agrawal is £296,848.42 to date, and that the Trust does not have insurance costs for legal awards in the event of the Trust or one of its employees being subject to legal action for defamation.

  • Nicholas Soames – 2016 Parliamentary Question to the Department of Health

    Nicholas Soames – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Nicholas Soames on 2016-07-20.

    To ask the Secretary of State for Health, when he or officials in his Department last met the Chairman or Chief Executive of the National Childbirth Trust.

    Mr Philip Dunne

    My Rt. hon. Friend the Secretary of State for Health has not met with the chair or chief executive of the National Childbirth Trust (NCT). However, my Rt. hon. Friend the then Parliamentary Under-Secretary of State (Ben Gummer), met with Nick Wilkie, chief executive of NCT, on 3 November 2015.

    Officials met with the chair of NCT, Helen Stephenson, and Nick Wilkie on 15 November 2015.

  • Peter Bottomley – 2016 Parliamentary Question to the Department of Health

    Peter Bottomley – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Peter Bottomley on 2016-07-20.

    To ask the Secretary of State for Health, for how many months Mr Aditya Agrawal was (a) employed and (b) not suspended by East Lancashire Hospitals Trust.

    Mr Jeremy Hunt

    This is an employer and employee matter between the East Lancashire Hospitals NHS Trust and Mr Aditya Agrawal respectively. The Department cannot comment on individual employment matters that are the responsibility of independent organisations, and that are subject to ongoing legal proceedings or on matters relating to individual clinical cases or other personal information. We understand that the cost to East Lancashire Trust of legal proceedings concerning Mr Agrawal is £296,848.42 to date, and that the Trust does not have insurance costs for legal awards in the event of the Trust or one of its employees being subject to legal action for defamation.

  • Peter Bottomley – 2016 Parliamentary Question to the Department of Health

    Peter Bottomley – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Peter Bottomley on 2016-07-20.

    To ask the Secretary of State for Health, which five clinical events caused the medical director of the East Lancashire Hospitals Trust to exclude Mr Aditya Agrawal.

    Mr Jeremy Hunt

    This is an employer and employee matter between the East Lancashire Hospitals NHS Trust and Mr Aditya Agrawal respectively. The Department cannot comment on individual employment matters that are the responsibility of independent organisations, and that are subject to ongoing legal proceedings or on matters relating to individual clinical cases or other personal information. We understand that the cost to East Lancashire Trust of legal proceedings concerning Mr Agrawal is £296,848.42 to date, and that the Trust does not have insurance costs for legal awards in the event of the Trust or one of its employees being subject to legal action for defamation.

  • Peter Bottomley – 2016 Parliamentary Question to the Department of Health

    Peter Bottomley – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Peter Bottomley on 2016-07-20.

    To ask the Secretary of State for Health, when the East Lancashire Hospitals Trust first checked the case notes of patient KM; and whether the medical director of that Trust wrote to Mr Agrawal to withdraw and to apologise for believing that the patient had died.

    Mr Jeremy Hunt

    This is an employer and employee matter between the East Lancashire Hospitals NHS Trust and Mr Aditya Agrawal respectively. The Department cannot comment on individual employment matters that are the responsibility of independent organisations, and that are subject to ongoing legal proceedings or on matters relating to individual clinical cases or other personal information. We understand that the cost to East Lancashire Trust of legal proceedings concerning Mr Agrawal is £296,848.42 to date, and that the Trust does not have insurance costs for legal awards in the event of the Trust or one of its employees being subject to legal action for defamation.

  • Helen Hayes – 2016 Parliamentary Question to the Department of Health

    Helen Hayes – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Helen Hayes on 2016-07-20.

    To ask the Secretary of State for Health, how GP practices will be able to access the planned additional investment in general practice of £2.4 billion per year by 2020-21.

    David Mowat

    The General Practice Forward View, published by NHS England on 21 April 2016, set out that investment in primary medical care will increase by £2.4 billion a year by 2020/21.

    Total funding to primary medical care includes core funding for practices, funding allocated locally by clinical commissioning groups, and centrally allocated funding from NHS England for the measures to help boost the workforce, drive efficiencies in workload and modernise primary care infrastructure and technology that are set out in the General Practice Forward View. The £2.4 billion will be delivered by both national and local level mechanisms.

    An advisory oversight group with patients and partners, including the British Medical Association’s General Practitioners Committee and the Royal College of General Practitioners, will steer implementation of the General Practice Forward View. NHS England is holding a number of events between July and September 2016 across the country to discuss the General Practice Forward View and its implications for local plans with general practitioners.

  • Helen Hayes – 2016 Parliamentary Question to the Department of Health

    Helen Hayes – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Helen Hayes on 2016-07-20.

    To ask the Secretary of State for Health, how many of the 1,500 clinical pharmacists pledged in the GP Forward View will have been brought in by the end of each financial year until April 2020.

    David Mowat

    NHS England has advised that the rollout of the additional 1,500 clinical pharmacists, as published in its General Practice Forward View, is still in the planning stage.

    As part of this work, NHS England is profiling the numbers for the rollout but cannot say at this time how many will be rolled out over each year.

    In July 2015 NHS England announced a £15 million pilot scheme to part fund and support general practices to recruit and employ clinical pharmacists to work alongside general practitioners (GPs) as part of the clinical team. In November 2015 this funding was more than doubled to £31 million, due to an overwhelmingly positive response from GP surgeries. These pharmacists will help to ease current pressures in general practice by working with patients who have long term conditions and others with multiple medications. Having a pharmacist on site will mean that patients who receive care from their general practice will be able to benefit from the expertise in medicines that these pharmacists provide.

  • David Amess – 2016 Parliamentary Question to the Department of Health

    David Amess – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by David Amess on 2016-07-20.

    To ask the Secretary of State for Health, with reference to Written Statement HCW588 on Infected Blood Payment Scheme, whether his Department has made an estimate of how many bereaved people will receive less support after 2016-17 than they do now.

    Nicola Blackwood

    The reformed scheme will provide a payment to all those with hepatitis C, even if they have been treated, for the current spending review period. A review of the scheme will take place towards the end of this spending review period.

    All those who are currently bereaved partners/spouses and all those who will be bereaved partner/spouses in future will receive a £10,000 lump sum payment and will have continued access to discretionary support. Discretionary support will continue to be available to the bereaved, as well as to infected individuals.

    All infected individuals who are registered with Skipton as having hepatitis C stage 1 (nearly 2,500 people) will be eligible for the new stage 1 annual payment.

  • David Amess – 2016 Parliamentary Question to the Department of Health

    David Amess – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by David Amess on 2016-07-20.

    To ask the Secretary of State for Health, whether everyone who was registered with Skipton and received the £20,000 lump sum payment will be automatically entitled to the new annual payments.

    Nicola Blackwood

    The reformed scheme will provide a payment to all those with hepatitis C, even if they have been treated, for the current spending review period. A review of the scheme will take place towards the end of this spending review period.

    All those who are currently bereaved partners/spouses and all those who will be bereaved partner/spouses in future will receive a £10,000 lump sum payment and will have continued access to discretionary support. Discretionary support will continue to be available to the bereaved, as well as to infected individuals.

    All infected individuals who are registered with Skipton as having hepatitis C stage 1 (nearly 2,500 people) will be eligible for the new stage 1 annual payment.

  • David Amess – 2016 Parliamentary Question to the Department of Health

    David Amess – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by David Amess on 2016-07-20.

    To ask the Secretary of State for Health, with reference to Written Statement HCW588 on Infected Blood Payment Scheme, whether entitlement to the new annual payments for people infected with hepatitis C via infected blood and blood products will continue for the lifetime of the individual even if they are successfully treated for their hepatitis C.

    Nicola Blackwood

    The reformed scheme will provide a payment to all those with hepatitis C, even if they have been treated, for the current spending review period. A review of the scheme will take place towards the end of this spending review period.

    All those who are currently bereaved partners/spouses and all those who will be bereaved partner/spouses in future will receive a £10,000 lump sum payment and will have continued access to discretionary support. Discretionary support will continue to be available to the bereaved, as well as to infected individuals.

    All infected individuals who are registered with Skipton as having hepatitis C stage 1 (nearly 2,500 people) will be eligible for the new stage 1 annual payment.